Bioxytran Interview at the Emerging Growth Conference
Wednesday, December 14, 2022 1:45pm –2:15pm EST Discussion of Clinical Trial Results BOSTON, MASSACHUSETTS, Dec. 12, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and …